Sample preparation of human serum for the analysis of tumor markers -: Comparison of different approaches for albumin and γ-globulin depletion

被引:101
作者
Govorukhina, NI
Keizer-Gunnink, A
van der Zee, AGJ
de Jong, S
de Bruijn, HWA
Bischoff, R
机构
[1] Univ Groningen, Dept Bioanal & Toxicol, Ctr Pharm, NL-9713 AV Groningen, Netherlands
[2] Univ Groningen Hosp, Dept Gynecol Oncol, NL-9713 GZ Groningen, Netherlands
[3] Univ Groningen Hosp, Dept Med Oncol, NL-9713 GZ Groningen, Netherlands
关键词
albumin; globulins; proteins;
D O I
10.1016/S0021-9673(03)00921-X
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
LC-MS is a powerful method for the sensitive detection of proteins and peptides in biological fluids. However, the presence of highly abundant proteins often masks those of lower abundance and thus generally prevents their detection and identification in proteomic studies. In human serum the most abundant proteins are albumin and gamma-globulins. We tested several approaches to specifically reduce the level of these proteins based on either specific antibodies, dye ligands (for albumin) and protein A or G (for gamma-globulins). The resulting, depleted serum was analyzed by sodium dodecylsulfate-polyacrylamide gel electrophoresis and LC-MS for the residual presence of these abundant proteins as well as for other serum proteins that should remain after depletion. To test the applicability of this method to real-life samples, depleted serum of a cervical cancer patient was analyzed for the presence of a specific tumor marker protein SCCA1 (squamous cell carcinoma antigen 1; P29508), which is present at ng/ml concentrations. The results demonstrate that SCCA1 can be detected by LC-MS in patient serum following depletion of albumin and gamma-globulins thus opening the possibility of screening patient sera for other, so far unknown, tumor markers. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:171 / 178
页数:8
相关论文
共 26 条
  • [1] AKERSTROM B, 1985, J IMMUNOL, V135, P2589
  • [2] AKERSTROM B, 1986, J BIOL CHEM, V261, P240
  • [3] The human plasma proteome - History, character, and diagnostic prospects
    Anderson, NL
    Anderson, NG
    [J]. MOLECULAR & CELLULAR PROTEOMICS, 2002, 1 (11) : 845 - 867
  • [4] BJORCK L, 1984, J IMMUNOL, V133, P969
  • [5] Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer
    Esajas, MD
    Duk, JM
    de Bruijn, HWA
    Aalders, JG
    Willemse, PHB
    Sluiter, W
    Pras, B
    ten Hoor, K
    Hollema, H
    van der Zee, AGJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (19) : 3960 - 3966
  • [6] CLONED STREPTOCOCCAL PROTEIN-G GENES
    FAHNESTOCK, SR
    [J]. TRENDS IN BIOTECHNOLOGY, 1987, 5 (03) : 79 - 83
  • [7] Georgiou HM, 2001, PROTEOMICS, V1, P1503, DOI 10.1002/1615-9861(200111)1:12<1503::AID-PROT1503>3.0.CO
  • [8] 2-M
  • [9] A GENERAL-METHOD FOR FRACTIONATION OF PLASMA-PROTEINS - DYE LIGAND AFFINITY-CHROMATOGRAPHY ON IMMOBILIZED CIBACRON BLUE F3GA
    GIANAZZA, E
    ARNAUD, P
    [J]. BIOCHEMICAL JOURNAL, 1982, 201 (01) : 129 - 136
  • [10] STRUCTURE OF THE IGG-BINDING REGIONS OF STREPTOCOCCAL PROTEIN-G
    GUSS, B
    ELIASSON, M
    OLSSON, A
    UHLEN, M
    FREJ, AK
    JORNVALL, H
    FLOCK, JI
    LINDBERG, M
    [J]. EMBO JOURNAL, 1986, 5 (07) : 1567 - 1575